title: Antithrombotic therapy in atrial fibrillation.
authors.affiliation: Clinical Epidemiology Unit, Ottawa Hospital, Civic Campus, ON, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Laupacis
authors.forename: G
authors.initials: G
authors.lastname: Albers
authors.forename: J
authors.initials: J
authors.lastname: Dalen
authors.forename: M I
authors.initials: MI
authors.lastname: Dunn
authors.forename: A K
authors.initials: AK
authors.lastname: Jacobson
authors.forename: D E
authors.initials: DE
authors.lastname: Singer
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control*; D004554:Electric Countershock; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin